Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • leekb
    Junior Member
    • Jul 2013
    • 7

    Fatty Liver Tissue ChIP Seq

    Hi all,

    I'm doing tissue ChIP seq using human liver tissue both in tumor and adjacent non tumor. I found that the liver tumor tissue always with so much fat/oil droplet and it seriously affect my ChIP so can't get enough DNA after pull down.

    Anyone can give me suggestions on how to deal with this problem? The tissues' weight always below 0.2g, I think trim the fat before ChIP not feasible as the fat stay inside the cells.

    And we interest in some TFs may not very abundant though.

    Thanks in advance!
  • doublestrand7
    Junior Member
    • Dec 2008
    • 2

    #2
    We have done lots of ChIP-Seq from liver and even from tumor and adjacent normal. These samples have never been a problem and never had problems with fat. If you can not get it to work Active Motif has an end-to-end ChIP-Seq service. http://www.activemotif.com/catalog/8...encing-service

    Comment

    • leekb
      Junior Member
      • Jul 2013
      • 7

      #3
      Originally posted by doublestrand7 View Post
      We have done lots of ChIP-Seq from liver and even from tumor and adjacent normal. These samples have never been a problem and never had problems with fat. If you can not get it to work Active Motif has an end-to-end ChIP-Seq service. http://www.activemotif.com/catalog/8...encing-service
      Hi doublestrand7,
      Nice to hear reply! Would you mind share a little bit more information about how many tissue you are using for IP? I'm doing AR ChIP-seq but sounds like not too much DNA pull down only 7ng using 50mg tissue both adj and tumor.

      Many thanks!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...